VDyne
PrivateLast Round
VC Round
Oct 24, 2022
Total Funding Raised
$21M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
VDyne is a medical device company developing a minimally invasive transcatheter valve replacement system to treat tricuspid regurgitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VDyne Comparables
Compare VDyne with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Laplace Interventional | 93% | |
| T-Heart | 93% | |
| Trisol Medical | 92% |
VDyne Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 24, 2022 | ||||
| Series C | Jan 6, 2021 |
VDyne Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jean Boulle Medtech | VC Round, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2026
Grew 28% QoQ from 39 to 50 employees.
- Aug 22, 2026
Monthly visitors increased 33% MoM.
Recent news
Latest coverage and updates
- is_developingJul 29, 2026
VDyne, Inc. is developing transcatheter tricuspid valve replacement system.
- is_developingJul 29, 2026
VDyne, Inc. was planning to develop transcatheter tricuspid valve replacement system for the treatment of tricuspid regurgitation on Jul 29th '26.
VDyne Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about VDyne's valuation, stock price, and market status.
Is VDyne a public or private company?
VDyne is a private company.
What is the current stock price of VDyne?
VDyne is a private company with no public stock price. No recent secondary market data is available.
How much is VDyne worth (valuation)?
Valuation information for VDyne is not publicly available.
Can I buy VDyne stock?
VDyne shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was VDyne's last funding round?
VDyne's most recent funding round was VC Round on October 24, 2022.
Who are the main investors in VDyne?
Key investors in VDyne include Jean Boulle Medtech.
Will VDyne IPO soon?
No public IPO plans have been announced for VDyne.
How can I track VDyne secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor VDyne's secondary market activity and sign up for updates.